1. Systematic review of perioperative and survival outcomes of liver resections with and without preoperative portal vein embolization for colorectal metastases
   Natasha Ironside et al, 2017, HPB CrossRef
2. Prognostic prediction of apparent diffusion coefficient obtained by diffusion‐weighted MRI in mass‐forming intrahepatic cholangiocarcinoma
   Shinichiro Yamada et al, 2020, Journal of Hepato-Biliary-Pancreatic Sciences CrossRef
3. Liver Tumor Microenvironment
   Diamantis I. Tsilimigras et al, 2020, Tumor Microenvironments in Organs CrossRef
4. Role of noninvasive imaging in the evaluation of intrahepatic cholangiocarcinoma: from diagnosis and prognosis to treatment response
   Qian Li et al, 2021, Expert Review of Gastroenterology & Hepatology CrossRef
5. Levels of soluble LR11/SorLA are highly increased in the bile of patients with biliary tract and pancreatic cancers
   Kensuke Terai et al, 2016, Clinica Chimica Acta CrossRef
6. Targeting Hypoxia Using Evofosfamide and Companion Hypoxia Imaging of FMISO-PET in Advanced Biliary Tract Cancer
   Jeesun Yoon et al, 2021, Cancer Research and Treatment CrossRef
7. Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives
   Mirella Pastore et al, 2020, Cells CrossRef
8. The Role of the Hedgehog Pathway in Cholangiocarcinoma
   Giulia Anichini et al, 2021, Cancers CrossRef
9. Correlation of an <i>ex Vivo</i> Model with Clinical Application of an Epigenetic Modifier, Inhibiting Tumor Growth and Metastasis, in Resistant Cholangiocarcinoma—A Case Study
   M. A. Nezami et al, 2016, Journal of Cancer Therapy CrossRef
10. MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment
    Pan Wang et al, 2019, Cell Death & Disease CrossRef
11. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells
    Runglawan Silakit et al, 2018, PLOS ONE CrossRef
12. The role of tumour microenvironment: a new vision for cholangiocarcinoma
    Ziyan Chen et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
13. Role of Glucose Metabolism Reprogramming in the Pathogenesis of Cholangiocarcinoma
    Kishor Pant et al, 2020, Frontiers in Medicine CrossRef
14. Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster
    Ashish Kumar Mishra et al, 2022, Cytokine CrossRef
15. Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?
    Yifan Wang et al, 2022, Current Oncology Reports CrossRef
16. Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis
    Merima Herac et al, 2016, APMIS CrossRef
17. Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
    Thitinee Vanichapol et al, 2018, BioMed Research International CrossRef
18. YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma
    Sungjin Ko et al, 2022, Hepatobiliary Cancers: Translational Advances and Molecular Medicine CrossRef
19. Comprehensive In silico analysis of chaperones identifies CRYAB and P4HA2 as potential therapeutic targets and their small-molecule inhibitors for the treatment of cholangiocarcinoma
    Manju Nidagodu Jayakumar et al, 2023, Computers in Biology and Medicine CrossRef
20. Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer
    Yuichiro Okumura et al, 2018, Annals of Surgical Oncology CrossRef
21. Epigenome Remodeling in Cholangiocarcinoma
    Colm J. O’Rourke et al, 2019, Trends in Cancer CrossRef